EUVIMED · CrossrefZeitschrift
memo - Magazine of European Medical Oncology
ISSN 1865-5041 · Springer Science and Business Media LLC
Neueste Artikel
Evolving treatment standards in metastatic non-clear cell renal cell carcinoma: reflecting a decade of progress
ASCO 2026 highlights—nongenetically driven non-small cell lung cancer
Evolving treatment algorithm for hormone receptor-positive, HER2-negative metastatic breast cancer: new drugs and future therapeutic strategies
The best of the best
Molecular profiling and targeted therapies in biliary tract cancer—a short review
Targeted therapies in advanced cholangiocarcinoma: new targets and strategies
Can artificial intelligence provide accurate and reliable answers to cancer patients’ questions about cancer pain? Comparison of chatbots based on ESMO cancer pain guideline
Next generation of drugs in breast cancer
ASCO 2020 non-small lung cancer (NSCLC) personal highlights
Chemotherapy-induced peripheral neuropathy (CIPN)
Update on squamous cell carcinoma of the head and neck
Visions have been realised
memo – New official Journal of CECOG
Mechanisms of tumour vascularisation
Angiogenesis as a therapeutic target in advanced breast cancer
Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations
Congress report: 12th World Conference on Lung Cancer – a step forward in lung cancer treatment. Seoul 2007
Future perspectives in the treatment of pancreatic cancer
Angiogenesis and anti-angiogenesis in haematological diseases
Erythropoietins in patients with cancer: an update
Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient
Announcement
(Neo-)adjuvant chemotherapy in breast cancer – Trials, errors and new rationales from the SABCS 2007
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology
Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?
Congress report: 49th Annual Meeting of the American Society of Haematology, Georgia World Congress Center, December 8–11 2007, Atlanta, Georgia
Adjuvant therapy in non-small cell lung cancer: Current status and future perspectives
Update on the treatment of hepatocellular carcinoma
Adjuvant chemotherapy in breast cancer
EUVIMED